Sponsor Deadline
Posted: 3/29/2023

NCCN Request for Proposals (RFP): NCCN Pfizer Investigator-Sponsored Research Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple Myeloma

The National Comprehensive Cancer Network® (NCCN) and Pfizer Global Medical Grants are collaborating to offer a new grant opportunity seeking proposals for investigator-sponsored research with elranatamab. Pfizer (hereafter, “Grantor”) is providing up to $5 Million Dollars in research grants to support clinical research studies to further evaluate the effectiveness of elranatamab in the treatment of Multiple Myeloma. The Grantor will serve as the funding organization. Grants are available to all investigators from institutions within the United States.  

LOI submission deadline: May 10, 2023 

Eligibility Requirements

Geographic Scope : United States

• Academic health care centers. • Community health care centers. • Health care professional organizations and other organizations related to health care improvement. • Health technology companies if partnered with a health care delivery organization who must serve as lead applicant. 

Amount Description

• There is up to $5 million available for funding of all projects. • The intent is to fund 3-5 studies. There is a funding cap of $1.25 million per study. Exceptional studies with budgets above this amount will be considered based on scientific merit and must contain a robust justification. 

Funding Type